phosphotyrosine has been researched along with Carcinoma, Lobular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirohashi, S; Kanai, Y; Kokubu, A; Sekine, S; Shibata, T | 1 |
| Heffelfinger, S; Lower, EE; Miller, MA; Westermann, C; Williams, L | 1 |
2 other study(ies) available for phosphotyrosine and Carcinoma, Lobular
| Article | Year |
|---|---|
Cytoplasmic p120ctn regulates the invasive phenotypes of E-cadherin-deficient breast cancer.
Topics: Base Sequence; Breast Neoplasms; Cadherins; Carcinoma, Lobular; Catenins; Cell Adhesion Molecules; Cell Division; Cell Movement; Delta Catenin; Female; Humans; Immunohistochemistry; Neoplasm Invasiveness; Oligodeoxyribonucleotides; Phosphoproteins; Phosphorylation; Phosphotyrosine; Plasmids; RNA, Small Interfering; Transfection | 2004 |
Increased phosphotyrosine in breast cancer tissue is associated with a worse prognosis.
Topics: Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Disease-Free Survival; Female; Humans; Neoplasm Staging; Phosphotyrosine; Predictive Value of Tests; Probability; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Retrospective Studies; Survival Rate; Time Factors | 1995 |